General Availability of the Fosfor Decision Cloud Debuts, Enabling Amplified Business Outcomes on the Snowflake AI Data Cloud
Fosfor today announced the general availability (GA) of its Fosfor Decision Cloud, a Snowflake-integrated platform that unifies the components of the modern data stack into a modern decision stack, built to simplify AI and amplify business outcomes. This robust and comprehensive data-to-decisions platform hits the market with Snowflake Partner Connect integration, Snowflake Technology Ready validation, and AI-enabling integrations.
The GA release builds on the success and adoption of the private preview version rolled out in February, adding:
- Snowflake Partner Connect integration, enabling users to easily, quickly, and securely enroll in a free Fosfor trial directly from their Snowflake accounts, making Fosfor’s business-outcome-enhancing capabilities readily available to all Snowflake customers.
- Snowflake Technology Ready validation, giving users the confidence that comes with a third-party technical validation to confirm Fosfor’s Snowflake integrations are optimized with an emphasis on functional and performance best practices.
- Integration with Snowflake’s latest AI capabilities, allowing users to streamline and simplify their AI journey by running AI directly where their data is already secure and governed. This is possible by leveraging Snowpark Container Services for ML lifecycle support and Snowflake Cortex AI for creating GenAI apps.
The GA release strengthens Fosfor’s commitment to Snowflake as its data and AI platform partner.
“General availability of the Fosfor Decision Cloud represents the culmination of our multi-year journey to simplify AI with the most comprehensive Decision Intelligence platform,” said Debasis Satpathy, Chief Business Officer, Fosfor. “This release delivers capabilities that expand the FDC’s suitability for a growing list of industries, and further strengthens our partnership with Snowflake, all in a stable, robust, enterprise-grade product.”
“Companies in every industry are looking for ways to more quickly realize return on their data and technology investments,” said Tarik Dwiek, Head of Technology Alliances, Snowflake. “The tightly integrated combination of the Fosfor Decision Cloud and the Snowflake AI Data Cloud provides the acceleration sought by customers looking to extract valuable insights from their data.”
The GA release of the Fosfor Decision Cloud is available now. Learn more at www.fosfor.com.
About Fosfor
The Fosfor Decision Cloud is a connected fabric that unifies and amplifies the value promised by the modern data ecosystem, which is made up of infrastructure, data, and application clouds. Fosfor enables organizations to effectively curate data, generate impactful insights, and formulate effective decisions to deliver the long-sought promise of data and AI: optimal business outcomes. Fosfor is part of LTIMindtree, a global technology consulting and digital solutions company. For more information, visit www.fosfor.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240903753120/en/
Contacts
Gitanjali Sreepal, Global Media Relations, Gitanjali.sreepal@ltimindtree.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Neuraptive Therapeutics Receives FDA Breakthrough Therapy Designation for NTX-001 and Provides Update on the Advancements of NTX-001 for the Treatment of Peripheral Nerve Injury Requiring Repair12.9.2024 01:05:00 EEST | Press release
Neuraptive Therapeutics, Inc. today announced that NTX-001 has been granted Breakthrough Therapy Designation, thus providing the potential for accelerated development for patients with peripheral nerve injury requiring repair. This designation follows the results from the Phase 2 NEUROFUSE study and several interactions with the FDA. NTX-001 has the potential to be a groundbreaking therapy in the field of nerve repair. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240911372663/en/ Evan L. Tzanis, Chief Operating Officer and EVP of R&D, Neuraptive Therapeutics, Inc. (Photo: Business Wire) Neuraptive is preparing to launch a Phase 3 pivotal program for NTX-001 in early 2025. The program will consist of a single randomized, double-blind, placebo-controlled study assessing the efficacy and safety of NTX-001 in patients with peripheral nerve injury requiring repair. The final protocol for this single Phase 3 study is currently b
Mouser Electronics Explores Sustainable Smart Grid Innovation in Latest Content Series11.9.2024 18:41:00 EEST | Press release
Mouser Electronics, Inc., the authorized global distributor with the newest electronic components and industrial automation products, today released the latest installment of its Empowering Innovation Together (EIT) technology series, which explores the benefits of incorporating renewable energy into smart grid technology, emphasizing the role of AI and 5G in achieving sustainable grid management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240911011855/en/ In the latest installment of its Empowering Innovation Together (EIT) technology series, Mouser explores the benefits of incorporating renewable energy into smart grid technology, emphasizing the role of AI and 5G in achieving sustainable grid management. (Photo: Business Wire) Adopting a smart grid system enhances the precision of power usage monitoring and energy distribution and enables two-way communication between the system and users. This decentralized approach
Delinea Named a Leader in 2024 Gartner ® Magic Quadrant™ for Privileged Access Management11.9.2024 18:30:00 EEST | Press release
Delinea, a pioneering provider of solutions for securing identities through centralized authorization, today announced its recognition as a Leader in the 2024 Gartner Magic Quadrant for Privileged Access Management (PAM). This marks the 6th consecutive time that Delinea has been acknowledged in the Leaders Quadrant; Delinea stated that, in their opinion, this highlights the company's ongoing commitment to delivering market-trusted security solutions. “We are honored to be recognized once again as a Leader by Gartner,” said Art Gilliland, CEO of Delinea. “Identity security serves as the first line of defense, as every identity, both human and non-human, and the data with which they interact are targets in today’s modern enterprises. I believe this acknowledgement reaffirms our commitment to safeguarding our clients while delivering solutions that not only enhance security but also remove complexity, elevating the user experience.” As Gartner states, “growth continues to be driven by the
CyberArk Named a Leader in the 2024 Gartner® Magic Quadrant™ for Privileged Access Management11.9.2024 18:04:00 EEST | Press release
CyberArk (NASDAQ: CYBR), the identity security company, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Privileged Access Management.1 CyberArk is positioned as a Leader for the sixth consecutive time and is positioned furthest in Completeness of Vision, which evaluates vendors on offering (product) strategy, innovation and market understanding among other evaluation criteria. With 93% of organizations suffering two or more identity-related breaches in the last 12 months, managing and securing identities has become a critical requirement. The CyberArk Identity Security Platform enables organizations to secure the entire spectrum of identities, including workforce, IT, developer and machine, supporting modern access use cases such as the need to enforce Zero Standing Privileges in public cloud environments. A core component of the platform is CyberArk’s privileged access management (PAM) capabilities, which allow customers to apply flexible privilege
Spencer Health Solutions Achieves ISO 27001 Certification11.9.2024 16:55:00 EEST | Press release
Spencer Health Solutions (SHS), a healthcare technology leader in smart medication management, announced that it has achieved ISO 27001:2022 certification. This prestigious accreditation underscores the company's unwavering commitment to safeguarding patient data and ensuring the highest standards of information security. ISO 27001 is a globally recognized information security management system (ISMS) standard that ensures organizations implement robust measures to protect their assets from threats. By achieving this certification, Spencer Health Solutions has demonstrated its dedication to: Confidentiality: Protecting patient data from unauthorized disclosure. Integrity: Ensuring the accuracy and completeness of medication dispensing records. Availability: Guaranteeing timely access to medication dispensing information when needed. “We are proud to announce that Spencer Health Solutions has achieved ISO 27001 certification,” said Tom Rhoads, CEO of Spencer Health Solutions. “This acco
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom